Bernd Boidol
Austrian Academy of Sciences(AT)CeMM Research Center for Molecular Medicine(AT)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, DNA Repair Mechanisms, Lymphoma Diagnosis and Treatment, Genomics and Chromatin Dynamics, Viral-associated cancers and disorders
Most-Cited Works
- → Systematic characterization of BAF mutations provides insights into intracomplex synthetic lethalities in human cancers(2019)141 cited
- → A strand-specific switch in noncoding transcription switches the function of a Polycomb/Trithorax response element(2014)108 cited
- → Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP 53 mutations(2017)102 cited
- → First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia(2017)71 cited
- → A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor(2017)50 cited
- → NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation(2014)45 cited
- → Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression(2016)22 cited
- → TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML(2017)15 cited
- → THE COMBINATION OF VENETOCLAX AND IBRUTINIB IS EFFECTIVE IN RELAPSED/REFRACTORY T‐PROLYMPHOCYTIC LEUKEMIA AND INFLUENCES BCL‐2‐FAMILY MEMBER DEPENDENCIES(2019)10 cited
- → Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia(2021)9 cited